Popular on TelAve
- WADA AWARDS - where Diamonds melt into glamour
- Rep. Gina H. Curry and Dr. Conan Tu Inspire at Kopp Foundation for Diabetes Hybrid Fundraising Gala and National Leadership Forum
- "Super Leftist", the new poetry book by Pierre Gervois
- Cracking the Code of AGI: Phinge to Solve AGI With Netverse Patented, App-less Integrated Verified Platform & Technologies Through its Hardware
- Frost Locker: New Research Reveals Mild Cold—Not Extreme Cold—Delivers Real Health Benefits of Cold Therapy
- Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets
- Phinge Effect: How Billions in VC Funding Could Shift From Current Tech, AI & App-Store Developers to Fund Third-Party Platform Developers on Netverse
- Los Angeles Community Recovery Investment Fund Launches Innovative Platform
- Jaipur's Savista Retreat announces $299 all-inclusive nightly rate for two for the 2026 season, including meals and city-center transfers
- RNHA FL Unveils Bold New Leadership Ahead of 2026 Elections
Similar on TelAve
- Revenue Optics Ignites AI Revolution in Industrial Distribution
- Arnica Unveils "Arnie AI" to Secure the Future of AI-Driven Software Development
- Axiros North America Announces New CEO: Gabriel Davidov
- CCHR Exposes Harms Behind Today's Mental Health Awareness Campaigns
- How to Optimize Your Website for AI Search with DeepRank AI
- DeployHub Joins Catalyst Campus SDA TAP Lab
- Parkchester Oral & Maxillofacial Surgery Celebrates 450+ 5-Star Reviews
- The AI CEO Partners with D3 Hockey News to Elevate the Voice of Division III Hockey Nationwide
- $430 Million 2026 Revenue Forecast; 26% Organic Growth; $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story: IQSTEL $IQST
- Wzzph Deploys 5-Million-TPS Trading Engine with Hot-Cold Wallet Architecture Serving 500,000 Active Users Across Latin America
VALFIX Medical Announces Issuance of New U.S. Patent for Its Heart Valve Repair and Replacement Technology
TelAve News/10580284
TEL AVIV, Israel - May 13, 2019 - TelAve -- VALFIX Medical Ltd. announces the issuance of US Patent No. 10,278,820 titled "Percutaneous valve repair and replacement" issued May 7, 2017. VALFIX Medical is developing trans-catheter solutions for patients suffering from valvular heart disease and heart failure.
"It is exciting to receive this patent as it confirms our technology patentability; our technology is unique and distinct in the market," stated Eli Bar, CEO and Founder of VALFIX Medical. " This patent granted confirms and protects our core technology and adds significant value to our stakeholders"
VALFIX Medical technology is distinguished in its approach to offer both repair and replacement treatment in one procedure. This unique toolbox approach gives more options for interventional cardiologists to deliver the most effective therapy to this complex condition.
More on TelAve News
Concurrently with the issuance of this patent, VALFIX Medical continues to develop its patent portfolio with other patents in preparation and pending.
About VALFIX Medical:
VALFIX Medical is developing the first complete trans-catheter solution which, based on its multi-wire technology, combines repair and replacement treatments for the Mitral and the Tricuspid valves; offering a viable alternative to open heart surgery.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or contact us directly at info@valfixmed.com
Recently, VALFIX Medical also announced the completion of its second round of investment and the recipience of a Research & Development grant from the Israeli Innovation Authority (https://www.valfixmed.com/blog).
"It is exciting to receive this patent as it confirms our technology patentability; our technology is unique and distinct in the market," stated Eli Bar, CEO and Founder of VALFIX Medical. " This patent granted confirms and protects our core technology and adds significant value to our stakeholders"
VALFIX Medical technology is distinguished in its approach to offer both repair and replacement treatment in one procedure. This unique toolbox approach gives more options for interventional cardiologists to deliver the most effective therapy to this complex condition.
More on TelAve News
- Netverse AI to Use Less Energy: Phinge's Verified AI & Patented App-Less Platform & Hardware Will Require Less Energy, Due to its Integrated Codebase
- How to Optimize Your Website for AI Search with DeepRank AI
- New Free Science Bingo Cards Help Grade 1 Students Learn Through Play
- DeployHub Joins Catalyst Campus SDA TAP Lab
- Veterans Day 2025: Virginia Veterans Can Claim Free Words of Veterans Book Vouchers
Concurrently with the issuance of this patent, VALFIX Medical continues to develop its patent portfolio with other patents in preparation and pending.
About VALFIX Medical:
VALFIX Medical is developing the first complete trans-catheter solution which, based on its multi-wire technology, combines repair and replacement treatments for the Mitral and the Tricuspid valves; offering a viable alternative to open heart surgery.
To learn more about VALFIX Medical visit our website at www.valfixmed.com or contact us directly at info@valfixmed.com
Recently, VALFIX Medical also announced the completion of its second round of investment and the recipience of a Research & Development grant from the Israeli Innovation Authority (https://www.valfixmed.com/blog).
Source: VALFIX Medical
Filed Under: Technology
0 Comments
Latest on TelAve News
- $430 Million 2026 Revenue Forecast; 26% Organic Growth; $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story: IQSTEL $IQST
- Wzzph Deploys 5-Million-TPS Trading Engine with Hot-Cold Wallet Architecture Serving 500,000 Active Users Across Latin America
- Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Dominate Raleigh's Best Awards from The News & Observer
- $73.6 Million Multi-Year Backlog and Florida State Term Contract Drive Momentum for AI-Cybersecurity Pioneer: Cycurion, Inc. (N A S D A Q: CYCU) $CYCU
- Year-Round Deals for Customers With Square Signs
- SecurePII Raises US$3.5M (A$5M) to Unlock AI and Compliance for Voice Data and Expands Global Presence
- Peter Coe Verbica Stands with Rural Families and Horse Owners: "Keep Horses Classified as Livestock"
- The Mobile-First Company Raises $12M to Build Simple, Powerful Software for Small Teams
- Lick Pineapple Flavored Massage Oil Outperforming and Enticing
- Cerberus ODC in Collaboration with NVIDIA Launches All-American AI-RAN Stack, Enabling AI-Native 5G Today and Accelerating the Path to 6G
- National Compliance Firm issues Artificial Intelligence Policy Program for Mortgage Banking
- Pastor Darrell Armstrong Suspends Gubernatorial Campaign And Endorses Mikie Sherrill
- Dr. Johnny Shanks Attends Full Arch Growth Conference 2025
- Offline Asset Protection: NJTRX Implements 98 Percent Cold Storage as Industry Faces 2 Billion USD Losses
- Thousands of Smiles, Millions of Logo Views: RoarFun Brings Emotions Into Premium Retail Spaces with Formula Simulator for Immersive Brand Activation
- Qvarz LLC Expands Global Reach with High-Precision Quartz Cuvettes and Optical Components
- $300 Million Web3 Initiative and ZIGChain Partnership Power $20 Target in Noble Capital Markets Report for SEGG Media (N A S D A Q: SEGG)
- Assent Recognizes Manufacturers for Leading Supply Chain Sustainability Programs
- Arc Longevity Sells Out Debut Women's Creatine Gummy
- Frost Locker: New Research Reveals Mild Cold—Not Extreme Cold—Delivers Real Health Benefits of Cold Therapy